A detailed history of Kbc Group Nv transactions in United Therapeutics Corp stock. As of the latest transaction made, Kbc Group Nv holds 115,886 shares of UTHR stock, worth $41.8 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
115,886
Previous 158,341 26.81%
Holding current value
$41.8 Million
Previous $50.4 Million 17.67%
% of portfolio
0.13%
Previous 0.15%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$311.04 - $363.55 $13.2 Million - $15.4 Million
-42,455 Reduced 26.81%
115,886 $41.5 Million
Q2 2024

Jul 17, 2024

BUY
$228.26 - $319.04 $35.3 Million - $49.3 Million
154,575 Added 4104.49%
158,341 $50.4 Million
Q4 2023

Feb 13, 2024

BUY
$214.88 - $256.94 $633,036 - $756,945
2,946 Added 359.27%
3,766 $828,000
Q3 2023

Feb 15, 2024

BUY
$211.82 - $248.24 $284,897 - $333,882
1,345 Added 164.02%
2,165 $489,000
Q2 2023

Feb 15, 2024

SELL
$205.19 - $232.99 $280,699 - $318,730
-1,368 Reduced 62.52%
820 $181,000
Q2 2023

Jul 28, 2023

BUY
$205.19 - $232.99 $9,849 - $11,183
48 Added 6.22%
820 $181,000
Q1 2023

Feb 14, 2024

SELL
$212.99 - $276.17 $211,499 - $274,236
-993 Reduced 56.26%
772 $173,000
Q1 2023

May 04, 2023

SELL
$212.99 - $276.17 $12,566 - $16,294
-59 Reduced 7.1%
772 $173,000
Q3 2022

Feb 15, 2024

SELL
$203.3 - $244.17 $320,807 - $385,300
-1,578 Reduced 41.9%
2,188 $458,000
Q2 2022

Feb 14, 2024

BUY
$174.81 - $241.14 $163,272 - $225,224
934 Added 112.39%
1,765 $416,000
Q1 2022

Feb 14, 2024

SELL
$166.16 - $213.96 $524,733 - $675,685
-3,158 Reduced 79.17%
831 $149,000
Q1 2022

May 06, 2022

SELL
$166.16 - $213.96 $524,733 - $675,685
-3,158 Reduced 79.17%
831 $149,000
Q4 2021

Feb 14, 2024

BUY
$184.32 - $216.08 $41,103 - $48,185
223 Added 5.92%
3,989 $862,000
Q4 2021

Feb 03, 2022

BUY
$184.32 - $216.08 $266,895 - $312,883
1,448 Added 56.99%
3,989 $862,000
Q3 2021

Nov 10, 2021

SELL
$179.86 - $214.88 $132,556 - $158,366
-737 Reduced 22.48%
2,541 $469,000
Q2 2021

Aug 11, 2021

BUY
$170.47 - $211.93 $558,800 - $694,706
3,278 New
3,278 $588,000
Q1 2021

Apr 26, 2021

SELL
$153.94 - $174.85 $2.37 Million - $2.69 Million
-15,401 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$101.87 - $151.79 $1.01 Million - $1.5 Million
9,908 Added 180.38%
15,401 $2.34 Million
Q3 2020

Oct 28, 2020

BUY
$99.9 - $121.13 $548,750 - $665,367
5,493 New
5,493 $555,000
Q1 2020

May 04, 2020

SELL
$79.39 - $115.35 $549,855 - $798,914
-6,926 Closed
0 $0
Q4 2019

Feb 11, 2020

SELL
$78.31 - $95.34 $209,714 - $255,320
-2,678 Reduced 27.88%
6,926 $610,000
Q1 2019

May 10, 2019

SELL
$107.15 - $126.84 $64,397 - $76,230
-601 Reduced 5.89%
9,604 $0
Q4 2018

Jan 31, 2019

SELL
$101.4 - $128.73 $478,912 - $607,991
-4,723 Reduced 31.64%
10,205 $1.11 Million
Q2 2018

Aug 03, 2018

SELL
$101.14 - $118.31 $26,498 - $30,997
-262 Reduced 1.72%
14,928 $0
Q1 2018

May 09, 2018

BUY
$107.21 - $151.94 $392,388 - $556,100
3,660 Added 31.74%
15,190 $0
Q4 2017

Feb 07, 2018

SELL
$118.58 - $151.28 $1.36 Million - $1.73 Million
-11,444 Reduced 49.81%
11,530 $0
Q3 2017

Nov 13, 2017

BUY
$114.6 - $136.81 $2.63 Million - $3.14 Million
22,974
22,974 $0

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.